Vaccine effectiveness in older individuals: What has been learned from the influenza-vaccine experience

Pierre Olivier Lang, Sheila Govind, Wayne A. Mitchell, Claire Anne Siegrist, Richard Aspinall

Research output: Contribution to journalReview article

44 Citations (Scopus)

Abstract

Vaccination policies in most high-income countries attempt to reduce the adverse impact of influenza targeting people aged at least 60 years. However, while it is widely believed that the current immunization strategy saves many lives, influenza infection still remains a severe burden in aged individuals leading to a wide debate on the exact magnitude of the benefit of vaccination in this population. The first aim of the present review is to examine how effective current influenza-vaccine strategies are in aged adults, by analysing which are the most important factors modulating the interpretation of study results in this population. Furthermore, consideration will be given to how immune factors influence the measurement of vaccine efficacy/effectiveness, where advancing age leads to deleterious changes in the adaptive immune system, resulting in less than optimal responses to infectious agents and vaccination. Finally this review concludes with possible strategies to improve the ability of the senescent immune system to respond to vaccination.

Original languageEnglish
Pages (from-to)389-395
Number of pages7
JournalAgeing Research Reviews
Volume10
Issue number3
Early online date30 Sep 2010
DOIs
Publication statusPublished - Jul 2011
Externally publishedYes

Fingerprint

Influenza Vaccines
Immune system
Vaccination
Vaccines
Immunization
Immunologic Factors
Human Influenza
Immune System
Population
Infection

Keywords

  • Cell-mediated immunity
  • Hemagglutinin inhibition
  • Immunosenescence
  • Influenza vaccine effectiveness
  • Innate immunity
  • Older adults

ASJC Scopus subject areas

  • Biotechnology
  • Biochemistry
  • Ageing
  • Molecular Biology
  • Neurology

Cite this

Vaccine effectiveness in older individuals : What has been learned from the influenza-vaccine experience. / Lang, Pierre Olivier; Govind, Sheila; Mitchell, Wayne A.; Siegrist, Claire Anne; Aspinall, Richard.

In: Ageing Research Reviews, Vol. 10, No. 3, 07.2011, p. 389-395.

Research output: Contribution to journalReview article

Lang, Pierre Olivier ; Govind, Sheila ; Mitchell, Wayne A. ; Siegrist, Claire Anne ; Aspinall, Richard. / Vaccine effectiveness in older individuals : What has been learned from the influenza-vaccine experience. In: Ageing Research Reviews. 2011 ; Vol. 10, No. 3. pp. 389-395.
@article{582857f2849f4e56ab184fdb67cb7b6b,
title = "Vaccine effectiveness in older individuals: What has been learned from the influenza-vaccine experience",
abstract = "Vaccination policies in most high-income countries attempt to reduce the adverse impact of influenza targeting people aged at least 60 years. However, while it is widely believed that the current immunization strategy saves many lives, influenza infection still remains a severe burden in aged individuals leading to a wide debate on the exact magnitude of the benefit of vaccination in this population. The first aim of the present review is to examine how effective current influenza-vaccine strategies are in aged adults, by analysing which are the most important factors modulating the interpretation of study results in this population. Furthermore, consideration will be given to how immune factors influence the measurement of vaccine efficacy/effectiveness, where advancing age leads to deleterious changes in the adaptive immune system, resulting in less than optimal responses to infectious agents and vaccination. Finally this review concludes with possible strategies to improve the ability of the senescent immune system to respond to vaccination.",
keywords = "Cell-mediated immunity, Hemagglutinin inhibition, Immunosenescence, Influenza vaccine effectiveness, Innate immunity, Older adults",
author = "Lang, {Pierre Olivier} and Sheila Govind and Mitchell, {Wayne A.} and Siegrist, {Claire Anne} and Richard Aspinall",
year = "2011",
month = "7",
doi = "10.1016/j.arr.2010.09.005",
language = "English",
volume = "10",
pages = "389--395",
journal = "Ageing Research Reviews",
issn = "1568-1637",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - Vaccine effectiveness in older individuals

T2 - What has been learned from the influenza-vaccine experience

AU - Lang, Pierre Olivier

AU - Govind, Sheila

AU - Mitchell, Wayne A.

AU - Siegrist, Claire Anne

AU - Aspinall, Richard

PY - 2011/7

Y1 - 2011/7

N2 - Vaccination policies in most high-income countries attempt to reduce the adverse impact of influenza targeting people aged at least 60 years. However, while it is widely believed that the current immunization strategy saves many lives, influenza infection still remains a severe burden in aged individuals leading to a wide debate on the exact magnitude of the benefit of vaccination in this population. The first aim of the present review is to examine how effective current influenza-vaccine strategies are in aged adults, by analysing which are the most important factors modulating the interpretation of study results in this population. Furthermore, consideration will be given to how immune factors influence the measurement of vaccine efficacy/effectiveness, where advancing age leads to deleterious changes in the adaptive immune system, resulting in less than optimal responses to infectious agents and vaccination. Finally this review concludes with possible strategies to improve the ability of the senescent immune system to respond to vaccination.

AB - Vaccination policies in most high-income countries attempt to reduce the adverse impact of influenza targeting people aged at least 60 years. However, while it is widely believed that the current immunization strategy saves many lives, influenza infection still remains a severe burden in aged individuals leading to a wide debate on the exact magnitude of the benefit of vaccination in this population. The first aim of the present review is to examine how effective current influenza-vaccine strategies are in aged adults, by analysing which are the most important factors modulating the interpretation of study results in this population. Furthermore, consideration will be given to how immune factors influence the measurement of vaccine efficacy/effectiveness, where advancing age leads to deleterious changes in the adaptive immune system, resulting in less than optimal responses to infectious agents and vaccination. Finally this review concludes with possible strategies to improve the ability of the senescent immune system to respond to vaccination.

KW - Cell-mediated immunity

KW - Hemagglutinin inhibition

KW - Immunosenescence

KW - Influenza vaccine effectiveness

KW - Innate immunity

KW - Older adults

UR - http://www.scopus.com/inward/record.url?scp=79955949208&partnerID=8YFLogxK

U2 - 10.1016/j.arr.2010.09.005

DO - 10.1016/j.arr.2010.09.005

M3 - Review article

VL - 10

SP - 389

EP - 395

JO - Ageing Research Reviews

JF - Ageing Research Reviews

SN - 1568-1637

IS - 3

ER -